Navigation Links
After a Stroke, When Seconds Count, Innovative Device from NeuroInterventions Speedily Restores Brain's Blood Flow
Date:10/11/2009

WASHINGTON, Oct. 11 /PRNewswire/ -- A new device from NeuroInterventions, Inc., is designed to minimize brain damage by dramatically speeding the delivery of post-stroke countermeasures.

"Stroke is the third most frequent cause of death, and the number-one cause of permanent disability," says NeuroInterventions President and COO Michele Migliuolo [mil-u-OLO]. "When a clot blocks the flow of oxygen-rich blood in the brain, the 'window' for surgical help is only a few hours wide. Every second can mean a drop in brain function."

So, driven by the emergency-room maxim, "Time is brain," NeuroInterventions has developed groundbreaking technology that enables surgeons to reach and remove clots in much less time than conventional approaches. Dr. Migliuolo will describe the development in a presentation today at AdvaMed 2009, at the Walter E. Washington Convention Center, Room 304, at 10:20 a.m.

"Even after a patient reaches a hospital, it can take up to 60 minutes just to introduce a conventional catheter through the femoral artery and steer it to the site, before you can deal with the clot," he says.

Capable of dissolving or extracting clots and delivering medication, the NeuroInterventions system takes a shorter, faster path to the brain. With exceptional maneuverability for negotiating the circulatory system, "Our devices will benefit patients, physicians, hospitals and insurance companies by improving outcomes through shorter, more effective treatment; by permitting more complex procedures; and by reducing recovery times."

Based in Pittsburgh, NeuroInterventions is prototyping a family of patent-pending catheters for addressing deep vein thrombosis, carotid stenting, and traumatic brain injury, in addition to stroke. The technology also facilitates localized drug and stem cell delivery.

On the management team are world leaders in interventional radiology, neurology and neurosurgery, as we
'/>"/>

SOURCE NeuroInterventions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ekkyo Presents a Positive Assessment one Year After the Launch of EkkyLite(TM), its New Scar Healing System
2. New Reconstruction Method Makes Speaking, Eating Possible After Tonsil Cancer Surgery, U-M Study Shows
3. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
4. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
5. UNT Health Science Centers Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
6. Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
7. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
8. Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis
9. Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
10. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
11. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Beamz Interactive, Inc. (OTCQB: BZIC), a leading ... that it has signed an agreement with RSL ... innovative prosthetic, orthotic and assistive technology products and ... RSL Steeper will promote and supply the Beamz ... within UK residential care facilities through its Assistive ...
(Date:12/17/2014)... Dec. 17, 2014  IGI Laboratories, Inc. (NYSE MKT: ... of its offering of $125 million aggregate principal amount ... The Notes were offered and sold only to qualified ... Act of 1933, as amended (the "Securities Act"). ... of 3.75% per year, payable semiannually in arrears on ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... Jan. 8, 2012  Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) announced today ... trial of its fully human monoclonal antibody against VEGF-C, ... The Phase 1 study will examine the safety ... with advanced solid tumours who have no other standard ...
... Jan. 7, 2012  Neurocrine Biosciences, Inc. (Nasdaq: ... founder and member of the Board of Directors, Wylie ... was a thoughtful leader with an incredible scientific mind ... by his terrific wit and disarming good nature.  He ...
Cached Medicine Technology:Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 2Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 3Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 4Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 5
(Date:12/17/2014)... (HealthDay News) -- Poor students get more fruits and vegetables ... finds. But, the opposite is true for students from ... vegetables at school may give a healthy boost to poor ... what the family income level, students all ate a similar ... The study was published recently in the journal ...
(Date:12/15/2014)... Grants Pass, OR (PRWEB) December 15, 2014 ... factors perceived by United States women as impacting skin ... – the “Four C’s of skin care.” Water and ... the conclusions in a recent article describing the survey ... her experience, every item in every category discussed would ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company , ... client, which allows users to keep track of wines ... the right wine. At the center of WineMatch ... and wine information. All this information is assembled to ... that are close counterparts to one another are called ...
(Date:12/15/2014)... Dallas,TX (PRWEB) December 15, 2014 The increase ... is one of the main factors which is contributing to ... used for the diagnosis and treatment of hearing loss and ... comprises of three parts - microphone, speaker and amplifier. The ... growth rate of 6.01% during the period from 2014 to ...
(Date:12/15/2014)... Toronto, Ontario (PRWEB) December 15, 2014 Bacteroides ... indoors. Not only is it much more prevalent than coliforms, ... not replicate in the environment. , Key Benefits of ... results for fecal contamination , Eliminates false positives ... Higher Specificity and Sensitivity , Maintain the ...
Breaking Medicine News(10 mins):Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
... risk of deaths from advanced prostate cancer is to catch// ... suggests that effective screening can prevent as much as 35% ... in men and is the second leading cause of death ... cancers are discovered when they have already spread to other ...
... clinical trials support the enhanced bioavailability// of CoQ10 delivered ... manufacturers of CoQ10 products. ,Increasing its bioavailability, ... and food makers to use lower dosages, therefore saving ... food-grade emulsifiers and solvents to trap water droplets in ...
... to be able to block the HIV virus from entering human ... major step forward in treatment of HIV. ,Scientist from ... fight against the AIDS virus. The research headed by Hiroaki Mitsuya ... States. The patients took 0.02 ounces of AK602 twice a day ...
... A study done by the researchers of Ohio State University ... your diet, you tend to prosper as well. ,The ... gain are quite strong among white female population of America. ... lost weight, but this is not particularly true for black ...
... infants with lung problem are often treated with inhaled nitric ... that this therapy does not reduce the chances of death ... of opinion that premature babies who weigh less than 1.5kgs ... are the part of a study. Inhaled nitric oxide therapy ...
... and can be a cause of Global warming//. ... World’ said: ,"Worldwide reduction of meat production in the pursuit ... carry fewer political unknowns than cutting our consumption of fossil ... and chicken burgers would do more for the environment. ...
Cached Medicine News:Health News:Screening For Prostate Cancer May Reduce Mortality Rate 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: